1.920USD-1.54%Mkt Cap: 1.99M USDP/E: —Last update: 2026-05-22
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measureme…
Industry Peers
Medical Devices152.25BUSDP/E 24.5
85.88BUSDP/E 24.2
53.45BSEKP/E 22.7
53.33BSEKP/E 98.9
52.13BDKKP/E 22.1
38.61BEURP/E 18.3
23.15BSEK—
22.25BEURP/E 23.4
loading…
Indicators:|
Key Statistics
Company
Market Cap1.99M USD
Enterprise Value-1.57M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.85M USD
Revenue/Share—
Last Price1.920 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.09
PEG—
EV/EBITDA0.23
EV/Revenue—
P/S—
P/B0.48
EPS (TTM)-3.74
EPS (Forward)-0.32
52W Range
1.6232% of range16.68
52W High16.68 USD
52W Low1.623 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-114.61%
ROA-96.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.05M USD
CapEx (TTM)173.74K USD
FCF Margin—
FCF Yield-206.42%
Net Debt-3.59M USD
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.02
Current Ratio2.81
Quick Ratio2.61
Book Value/Sh4.041 USD
Cash/Share3.561 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJan 29, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.03M
Float844.45K
Insiders11.22%
Institutions10.62%
Short Interest
Short Ratio1.4d
Short % Float2.21%
Short % Out.2.08%
Shares Short21.48K
Short (prev mo.)42.96K
Technical
SMA 501.888 (+1.7%)
SMA 2004.327 (-55.6%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)23.33K
Avg Vol (10d)34.42K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—